Pharmaceuticals

Debt Recovery

Advisor to a German investment bank to recover its default loan (USD14 million) to a Tianjin group of companies which is primarily engaged in the production and distribution of pharmaceutical products including medical supplies, prescription and over-the- counter drugs. The group has a production plant in Tianjin with 11 buildings, 9 production lines and 56 sets of equipment and machinery. Our work included investigation in relation to the group’s financial and operational status, identifying and assessing the options available to the bank, and establishing a work plan for the enforcement of the bank’s mortgage over assets in Tianjin while seeking other more amicable and quick solution from the group and other stakeholders.

Key People